v3.26.3
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2026
Equity Controlling Interest  
Schedule of Common Stock

Conversion of debt to equity   62,586 

Granted in lieu of cash

   504,592 
Direct placement of common stock   

349,980

 

Sales of common stock to public investors

   

230,014

 
Issued for acquisition   

352,207

 

Issued under stock purchase agreement

   

300,680

 
Total   1,800,059 
Schedule of Common Stock Warrants

           Weighted     
       Weighted   Average     
       Average   Remaining   Aggregate 
   Number of   Exercise   Contractual   Intrinsic 
   Shares   Price   Life (years)   Value 
Outstanding at December 31, 2024   33,821   $50.44    3.9   $- 
Granted   97,487    -    4.5    - 
Exercised   (37,520)   -    -    -
Forfeited/cancelled   (327)  $304.02    -    - 
Outstanding at December 31, 2025   60,173   $50.45    2.0    112,151 
Granted   -    -    -    - 
Exercised   (60,151)   -    -    - 
Forfeited/cancelled   -    -    -    - 
Outstanding at March 31, 2026   22   $212.81    1.79   $-